Canada markets closed

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
11.600-0.120 (-1.02%)
At close: 04:08PM HKT
Full screen
Previous Close11.720
Open11.640
Bid11.600 x 0
Ask11.620 x 0
Day's Range11.520 - 11.800
52 Week Range10.880 - 52.450
Volume31,518,947
Avg. Volume60,051,612
Market Cap48.155B
Beta (5Y Monthly)0.58
PE Ratio (TTM)13.98
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment

    WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today published its 2023 Environmental, Social and Governance (ESG) Report, highlighting the company's substantial progress in advancing sustainable development.

  • PR Newswire

    WuXi Biologics Reports Solid 2023 Annual Results

    WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for biologics discovery, development and manufacturing, is pleased to announce its audited annual results for the year ended December 31, 2023 ("Reporting Period").

  • PR Newswire

    WuXi Biologics Named to CDP 'A List' for Water Security

    WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been recognized for leadership in corporate transparency and performance on water security by the environmental non-profit CDP, securing a place on its annual 'A List'.